News from prime therapeutics llc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 02, 2022, 09:00 ET Prime Therapeutics finds $1.1 million waste reduction opportunity with medically integrated dispensing compared to central specialty pharmacy

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) analyzed its real-world data to assess clinical outcomes and drug waste...

May 23, 2022, 09:00 ET Prime Therapeutics' MedDrive™ program leverages biosimilars to cut member drug expenses by 26% in one year

Prime Therapeutics LLC (Prime) announced that its MedDrive™ program achieved significant savings in its first year, with biosimilars for treating...

May 05, 2022, 09:00 ET Prime Therapeutics is acquiring Magellan Rx to advance integrated specialty drug management, accelerating efforts to lower the cost of drugs and improve health outcomes

Pharmacy benefit manager Prime Therapeutics LLC (Prime) on May 3 entered into a definitive agreement with Centene Corporation to acquire Magellan...

Apr 11, 2022, 09:02 ET ClearStone Solutions selects Prime Therapeutics as pharmacy benefit manager

Prime Therapeutics LLC (Prime) announced today that they will begin administering Medicare Part D business pharmacy benefits for ClearStone Solutions ...

Feb 25, 2022, 10:00 ET Prime Therapeutics unveils inaugural diversity, equity and inclusion (DEI) transparency report

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) today announces its Diversity, Equity and Inclusion (DEI) Annual Transparency...

Jan 27, 2022, 09:00 ET Prime Therapeutics earns perfect score on Human Rights Campaign Foundation's 2022 Corporate Equality Index

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) proudly announces its top score on the Human Rights Campaign Foundation's 2022...

Jan 20, 2022, 09:07 ET Prime Therapeutics earns re-accreditations from URAC, NCQA

In a demonstration of its commitment to quality health care, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving nearly...

Jan 11, 2022, 09:34 ET Prime Therapeutics introduces HighTouchRx™ pharmacist outreach program using both medical and pharmacy data to help maximize savings

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) announces the launch of HighTouchRx™. The award-winning program applies machine ...

Nov 03, 2021, 09:00 ET Prime Therapeutics backs first interchangeable insulin biosimilar Semglee®

Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving nearly 33 million members, will be preferring Viatris' biosimilar...

Oct 19, 2021, 10:00 ET Going beyond the first fill: Prime Therapeutics, NCODA collaboration enables improved patient outcomes through new oncology pharmacy accreditation

Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM) serving more than 33 million members, will prefer for its IntegratedRx™ -...

Oct 18, 2021, 11:00 ET Cancer patients, caregivers benefit with integrated clinic-to-pharmacy care through Prime Therapeutics' IntegratedRx™ - Oncology

Prime Therapeutics, a leading pharmacy benefit manager (PBM) serving more than 33 million members, today introduced IntegratedRx™ - Oncology. This...

Oct 14, 2021, 09:02 ET In first of its kind study, Prime Therapeutics explores paroxysmal nocturnal hemoglobinuria (PNH) C5 inhibitor treatment rates

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) used its integrated medical and pharmacy claims data to evaluate paroxysmal...

Oct 06, 2021, 10:00 ET Prime Therapeutics launches new MedsYourWay™ offering, now giving Blue Plan members home delivery prescription option using Amazon Pharmacy

Prime Therapeutics LLC, a leading pharmacy benefit manager, announces its new MedsYourWay™ offering, designed to deliver breakthrough consumer...

Sep 27, 2021, 14:00 ET Prime Therapeutics welcomes Chris Knibb as Chief Financial Officer

Chris Knibb, an accomplished finance executive with more than 25 years of financial and business leadership, has joined Prime Therapeutics LLC...

Aug 11, 2021, 09:05 ET Prime Therapeutics' Advanced Fraud, Waste and Abuse Program Saved its Health Plan Clients $285 Million in 2020

In the second full year of its advanced fraud, waste and abuse (FWA) program, Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM)...

May 26, 2021, 09:00 ET Prime Therapeutics launches MedDrive™, a first-of-its kind medical drug management program uniquely aligned with its Blue Plan clients

Today, Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM) serving nearly 33 million members across 23 Blue Plans, unveiled...

May 11, 2021, 09:05 ET Prime Therapeutics proactive prescriber outreach significantly improves statin use in Medicare members with diabetes

Using a proactive prescriber outreach program, Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 33 million members...

May 06, 2021, 09:00 ET Ken Paulus signs CEO Action for Diversity & Inclusion pledge

Prime Therapeutics LLC's (Prime) President and CEO Ken Paulus is joining over 2,000 other chief executive officers by signing the CEO Action for...

May 05, 2021, 09:00 ET Prime Therapeutics Ups Its Predictive Analytics Game with Differentiated Integrated Data Platform

Prime Therapeutics LLC (Prime) introduces Insights+, its highly consultative data and analytics platform that gives clients timely access to their...

Apr 26, 2021, 17:00 ET Prime Therapeutics applauds new legislation to drive greater biosimilar uptake, lower total cost of care

Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving approximately 33 million members nationally, released the following...

Apr 26, 2021, 09:05 ET Prime Therapeutics welcomes new client success leader

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 33 million members nationally, announces the hiring of Karen DeZearn, ...

Apr 12, 2021, 09:00 ET Prime Therapeutics' study shows total cost of care for CAR-T plus post-treatment events can exceed $1 million

Blue Cross and Blue Shield plans can better forecast and manage the total cost of chimeric antigen receptor T-cell (CAR-T) therapies for members with ...

Apr 07, 2021, 08:00 ET Prime Therapeutics studies: Integrated pharmacy, medical data inform effective drug therapy management for high-cost conditions

Armed with insights from substantive, real-world data, Blue Cross and Blue Shield plans that partner with Prime Therapeutics LLC (Prime) are now more ...

Dec 28, 2020, 15:00 ET Notice of incorrect information sent to some Washington health plan members

Prime Therapeutics LLC (Prime) recently learned of a privacy incident that affected a subset of its covered members. Prime administers prescription...

Dec 22, 2020, 08:30 ET Prime Therapeutics' predictive model expands efforts to reduce potential misuse and abuse of opioids

In an effort to help identify both new and prior users of opioids who may be at risk for opioid use harm and to ultimately help prevent misuse, Prime ...